DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Elspar (Asparaginase) - News

 
 



News related to Elspar (Asparaginase) and/or conditions it is approved for

In highly lethal type of leukemia, cancer gene predicts treatment response
Source: Cancer / Oncology News From Medical News Today [2016.11.25]
Patients with the most lethal form of acute myeloid leukemia (AML) - based on genetic profiles of their cancers - typically survive for only four to six months after diagnosis, even with aggressive...

Potential targeted therapy found for newly identified leukemia subtype with poor outcome
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.11.10]
An international research team led by St. Jude Children's Research Hospital investigators has uncovered details of a new, high-risk subtype of acute lymphoblastic leukemia (ALL) as well as a...

Genetic hallmarks of acute lymphoblastic leukemia subtype uncovered
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.10.25]
St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project team identifies genetic changes underlying a type of B-precursor acute lymphoblastic leukemiaAn...

Low cost method for examining single leukemia cells could transform treatment
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.10.18]
Leukemia is a disease in which each cell can exhibit different genetic traits, and now Swedish researchers have found a cheap way to examine the individual cells.

New treatment approach for leukemia renders cancer genes powerless
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.10.14]
In leukemia cells it is often the case that genes are reactivated that, in physiological terms, mediate the self-renewal of blood stem cells.

New immunotherapy for leukemia shows promise in small clinical trial
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.10.03]
A new type of immunotherapy shows promise against cases of acute myeloid leukemia (AML) that recur after treatment or that never respond to therapy in the first place.

Experimental Immune Cell Rx Shows Promise for Leukemia
Source: MedicineNet Leukemia Specialty [2016.09.22]
Title: Experimental Immune Cell Rx Shows Promise for Leukemia
Category: Health News
Created: 9/21/2016 12:00:00 AM
Last Editorial Review: 9/22/2016 12:00:00 AM

Brain cancer and leukemia: New molecular mechanisms decoded
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.09.16]
A joint research published in Nature Communications has shown new molecular causes of brain cancer and leukemia.

Many adolescent girls with leukemia are not being screened for pregnancy before beginning chemotherapy
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.09.13]
A new study indicates that adolescent females with acute leukemia have low rates of pregnancy screening prior to receiving chemotherapy that can cause birth defects.

Venetoclax safe, shows promise in patients with acute myelogenous leukemia
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.08.16]
Patients whose acute myelogenous leukemia (AML) had relapsed or was resistant to chemotherapy and those who were deemed unable to tolerate chemotherapy experienced responses to the selective BCL-2...

Leukemia
Source: MedicineNet Eosinophilic Fasciitis Specialty [2016.02.03]
Title: Leukemia
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 2/3/2016 12:00:00 AM

New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.

Prevalence of Ph-like ALL in adults underscores need for genetic testing, clinical trials
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.11.22]
A high-risk subtype of acute lymphoblastic leukemia (ALL) first identified in children is highly prevalent in adults with ALL and is associated with a poor outcome, according to an international...

Researchers develop new strategy to limit side effects of stem cell transplants
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.08.16]
Scientists in Germany have developed a new approach that may prevent leukemia and lymphoma patients from developing graft-versus-host disease (GvHD) after therapeutic bone marrow transplants.

Cord blood outperforms matched, unrelated donor in bone marrow transplant
Source: Transplants / Organ Donations News From Medical News Today [2016.07.28]
A University of Colorado Cancer Center study compared outcomes of leukemia patients receiving bone marrow transplants from 2009-2014, finding that three years post transplant, the incidence of...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015